[EXPLANATORY NOTE Th Description 99.1* Press Release,ted August 26, 2013 101.INS XBRL Instance Document 101.SCH XBRL Taxonomy Extensionhema Document 101.CAL XBRL Taxonomy Extensionlculation Linkbase Document 101.LAB XBRL Taxonomy Extension Label Linkbase Document 101.PRE XBRL Taxonomy Extension Presentation Linkbase Document * Previously filed. CHINARD BLOODRPORATIONbert Chen]
[EXPLANATORY NOTE Th Description 99.1* Press Release,ted August 26, 2013 101.INS XBRL Instance Document 101.SCH XBRL Taxonomy Extensionhema Document 101.CAL XBRL Taxonomy Extensionlculation Linkbase Document 101.LAB XBRL Taxonomy Extension Label Linkbase Document 101.PRE XBRL Taxonomy Extension Presentation Linkbase Document * Previously filed. CHINARD BLOODRPORATIONbert Chen]
[October 17, 2013 John Reynolds Re: China Cord Blood Corporation Registration Statement on Form F-3 Filed September 12, 2013 File No. 333-191121 Supplemental Response Letter Dated October 2, 2013 Dear Mr. Reynolds: We hereby provide responses to comments issued on October 11, 2013 (the “Staff’s Letter”) regarding the Registration Statement on Form F-3 (File No. 333-191121)(the “F-3”) of China Cord]
[October 17, 2013 John Reynolds Re: Chinard Bloodrporation Registration Statement on Form F-3 Filed September 12, 2013 File No. 333-191121 Supplemental Response Letterted October 2, 2013 Dear Mr. Reynolds: We hereby provide responses tomments issued on October 11, 2013 (the Staffs Letter) regarding the Registration Statement on Form F-3 (File No. 333-191121)(the F-3) of Chinard]
[October 2, 2013 John Reynolds Re: China Cord Blood Corporation Registration Statement on Form F-3 Filed September 12, 2013 File No. 333-191121 Dear Mr. Reynolds: We hereby provide responses to comments issued on September 26, 2013 (the “Staff’s Letter”) regarding the Registration Statement on Form F-3 (File No. 333-191121)(the “F-3”) of China Cord Blood Corporation (the “Company”). In order to]
[October 2, 2013 John Reynolds Re: China Cord Blood Corporation Registration Statement on Form F-3 Filed September 12, 2013 File No. 333-191121 Dear Mr. Reynolds: We hereby provide responses to comments issued on September 26, 2013 (the “Staff’s Letter”) regarding the Registration Statement on Form F-3 (File No. 333-191121)(the “F-3”) of China Cord Blood Corporation (the “Company”). In order to]
